Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1,511 INR | -0.52% | +1.78% | +19.98% |
Sales 2024 * | 485B 5.82B | Sales 2025 * | 538B 6.46B | Capitalization | 3,645B 43.71B |
---|---|---|---|---|---|
Net income 2024 * | 93.04B 1.12B | Net income 2025 * | 113B 1.35B | EV / Sales 2024 * | 7.31 x |
Net cash position 2024 * | 97.98B 1.18B | Net cash position 2025 * | 161B 1.93B | EV / Sales 2025 * | 6.47 x |
P/E ratio 2024 * |
38.9
x | P/E ratio 2025 * |
32.3
x | Employees | 41,000 |
Yield 2024 * |
0.81% | Yield 2025 * |
0.94% | Free-Float | 45.31% |
Latest transcript on Sun Pharmaceutical Industries Ltd.
1 day | -0.68% | ||
1 week | +1.62% | ||
Current month | -6.91% | ||
1 month | -7.40% | ||
3 months | +9.98% | ||
6 months | +35.28% | ||
Current year | +19.79% |
Managers | Title | Age | Since |
---|---|---|---|
Aalok Shanghvi
CEO | Chief Executive Officer | - | - |
Founder | 68 | 81-12-31 | |
Director of Finance/CFO | - | 17-06-18 |
Members of the board | Title | Age | Since |
---|---|---|---|
Founder | 68 | 81-12-31 | |
Rama Bijapurkar
BRD | Director/Board Member | 67 | 21-05-20 |
Rolf K. Hoffmann
BRD | Director/Board Member | 64 | 23-06-14 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
1.72% | 6 M€ | +6.07% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-03 | 1,511 | -0.52% | 3 183 226 |
24-05-02 | 1,519 | +1.13% | 2,494,925 |
24-04-30 | 1,502 | -1.28% | 1,991,646 |
24-04-29 | 1,522 | +1.00% | 1,091,667 |
24-04-26 | 1,507 | -0.89% | 1,794,350 |
Delayed Quote NSE India S.E., May 03, 2024 at 05:43 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+19.79% | 43.67B | |
+20.67% | 22.51B | |
+14.04% | 14.6B | |
+14.32% | 13.74B | |
+44.87% | 11.91B | |
-8.37% | 7.04B | |
-0.05% | 6.79B | |
-8.87% | 5.73B | |
+10.21% | 5.42B | |
-2.27% | 4.81B |
- Stock Market
- Equities
- SUNPHARMA Stock